Jul 18, 2026 12:40PM
Jul 11, 2026 12:30PM
Jul 8, 2026 07:30AM
Jul 4, 2026 12:25PM
Jun 27, 2026 02:40PM
Jun 12, 2026 04:39PM
Jun 6, 2026 11:20AM New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
Jun 2, 2026 08:15AM
May 30, 2026 11:55AM
May 23, 2026 12:25PM
May 7, 2026 09:01AM
Apr 25, 2026 12:55PM
Apr 24, 2026 09:25AM
Apr 24, 2026 09:00AM Join Lantern Pharma on April 30 for the First Public Demonstration of with Zeta.ai - A Platform to Conquer Rare Cancers
Apr 20, 2026 08:05AM
Apr 20, 2026 08:00AM
Apr 14, 2026 08:36AM
Apr 2, 2026 08:45AM
Mar 27, 2026 07:00AM
Mar 21, 2026 01:55PM
Jan 20, 2026 08:04AM Lantern Pharma's LP-284 gets FDA orphan drug status for soft tissue sarcoma
Jan 12, 2026 09:01AM
Dec 27, 2025 05:00PM
Nov 8, 2025 11:40AM
Nov 7, 2025 09:00AM
Oct 28, 2025 08:50AM
Oct 3, 2025 09:00AM
Sep 16, 2025 08:27AM Lantern Pharma (LTRN) Halted, News Pending
Sep 3, 2025 09:44AM
Aug 19, 2025 08:00AM
Aug 13, 2025 06:08PM
Aug 6, 2025 08:30AM
Aug 4, 2025 08:55AM
Jul 25, 2025 09:00AM
Jul 21, 2025 08:20AM Lantern Pharma receives EU patent allowance for AI-developed cancer drug LP-284
Jul 15, 2025 09:40AM
May 29, 2025 08:35AM
May 15, 2025 05:03PM
May 12, 2025 09:00AM
Feb 19, 2025 08:02AM
Jan 27, 2025 08:04AM
Dec 3, 2024 08:05AM Lantern Pharma (LTRN) Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer
Nov 26, 2024 08:45AM
Nov 7, 2024 04:49PM
Oct 15, 2024 09:07AM
Sep 23, 2024 08:00AM
Jul 10, 2024 08:32AM
Jun 12, 2024 07:31AM

418,486 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All